Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles-Reference-Cited by-同舟云学术

Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles

Published:2019-06 Issue: Volume:114 Page:108820
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yugui Fu,Wang Hailan,Sun Dezhong,Zhang Xiaoyan

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery;Wang;Expert Opin. Pharmacother.,2016

2. Advances in systemic treatment for nasopharyngeal carcinoma;Tan;Chin. Clin. Oncol.,2016

3. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis;Blanchard;Lancet Oncol.,2015

4. Berberine hydrochloride-loaded chitosan nanoparticles effectively targets and suppresses human nasopharyngeal carcinoma;Wang;J. Biomed. Nanotechnol.,2018

5. Chemotherapy for nasopharyngeal carcinoma - current recommendation and controversies;Sze;Hematol. Oncol. Clin. North Am.,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy;Biomedicines;2024-02-21

2. Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer;International Journal of Pharmaceutics;2024-01

3. Hybrid multifunctional nanomaterials for cancer diagnostics and therapeutics;Functionalized Nanomaterials for Cancer Research;2024

4. Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics;Medicine in Drug Discovery;2023-12

5. Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer;ACS Applied Nano Materials;2023-11-18